Accel Research Site - Achieve - Birmingham - ERN - PPDS — Birmingham, Alabama

Accel Research Site - Achieve - Birmingham - ERN - PPDS is a clinical research site located in Birmingham, Alabama, United States 35216.

Crixeo Health Trust Score: 61/100 (FAIR). This profile has not yet been claimed by the site owner.

Accel Research Site - Achieve - Birmingham - ERN - PPDS has participated in 3 clinical trials.

Therapeutic areas: SARS-CoV-2 Infection, Cytomegalovirus Infection, Respiratory Syncytial Virus.

Sponsors: Shionogi, ModernaTX, Inc..

Sponsor Feasibility Report

Trust Score: 61/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Accel Research Site - Achieve - Birmingham - ERN - PPDS?

Accel Research Site - Achieve - Birmingham - ERN - PPDS has a Crixeo Trust Score of 61/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Accel Research Site - Achieve - Birmingham - ERN - PPDS conducted?

Accel Research Site - Achieve - Birmingham - ERN - PPDS has 3 clinical trials on record. Their work covers SARS-CoV-2 Infection, Cytomegalovirus Infection, Respiratory Syncytial Virus.

Is Accel Research Site - Achieve - Birmingham - ERN - PPDS accredited by Crixeo Health?

Accel Research Site - Achieve - Birmingham - ERN - PPDS has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Accel Research Site - Achieve - Birmingham - ERN - PPDS?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.